Correlates of cervical mucosal antibodies to human papillomavirus 16: Results from a case control study
- 31 December 2005
- journal article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 99 (3), S262-S268
- https://doi.org/10.1016/j.ygyno.2005.07.100
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Immune responses induced by lower airway mucosal immunisation with a human papillomavirus type 16 virus-like particle vaccineVaccine, 2005
- Specific serologic response to genital human papillomavirus types in patients with vulvar precancerous and cancerous lesionsAmerican Journal of Obstetrics and Gynecology, 2005
- Immune responses to human papillomavirus in genital tract of women with cervical cancerGynecologic Oncology, 2005
- Mucosal IgG and IgA Responses to Human Papillomavirus Type 16 Capsid Proteins in HPV16-Infected Women without Visible PathologyViral Immunology, 2003
- Mucosal immunoglobulin-A and -G responses to oncogenic human papilloma virus capsidsInternational Journal of Cancer, 2003
- Seroprevalence of Human Papillomavirus Type 16 Infection in the United StatesThe Journal of Infectious Diseases, 2002
- Risk Factors for Subsequent Cervicovaginal Human Papillomavirus (HPV) Infection and the Protective Role of Antibodies to HPV‐16 Virus‐Like ParticlesThe Journal of Infectious Diseases, 2002
- Optimization of a Human Papillomavirus-Specific Enzyme-Linked Immunosorbent AssayClinical and Vaccine Immunology, 2002
- Comparison of Human Papillomavirus Types 16, 18, and 6 Capsid Antibody Responses Following Incident InfectionThe Journal of Infectious Diseases, 2000
- Detection of Cervical Antibodies to Human Papillomavirus Type 16 (HPV‐16) Capsid Antigens in Relation to Detection of HPV‐16 DNA and Cervical LesionsThe Journal of Infectious Diseases, 2000